SLC43A2 Knockout HEK293 Cell Line
Cat.No.:
EDC08115
Species:
Human
Cell Name:
HEK293
Gene:
SLC43A2
Gene ID:
124935
Size:
1×10⁶cells
SLC43A2 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08115 |
|---|---|
| Product Name | SLC43A2 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | SLC43A2 |
| NCBI Gene ID | |
| Gene Synonyms | LAT4 |
| Summary |
This gene encodes a member of the L-amino acid transporter-3 or SLC43 family of transporters. The encoded protein mediates sodium-, chloride-, and pH-independent transport of L-isomers of neutral amino acids, including leucine, phenylalanine, valine and methionine. This protein may contribute to the transfer of amino acids across the placental membrane to the fetus. [provided by RefSeq, Mar 2016]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC43A2 function, SLC43A2 Knockout HEK293 Cell Line or SLC43A2 overexpression HEK293 Cell Line?
The choice depends on whether you are studying SLC43A2 (LAT4)'s role in basolateral large neutral amino acid efflux or its specific contributions distinct from LAT1/LAT2. The Knockout line is the standard tool for asking whether LAT4 is required for sodium-independent transport of branched-chain amino acids (leucine, isoleucine, valine), methionine, and phenylalanine — particularly relevant in epithelial transepithelial amino acid handling. Overexpression is useful for transport kinetics studies — notably, LAT4 functions independently of 4F2hc unlike LAT1 and LAT2.
For LAT family research, the EDITGENE SLC43A2 Knockout in HEK293 is a mechanistic platform distinct from heterodimeric LAT1/LAT2 — LAT4 is a uniporter that does not require 4F2hc partnership, simplifying transport activity reconstitution. Rescue with wild-type or transport-deficient LAT4 enables structure-function studies and substrate specificity characterization independent of heterodimer assembly considerations.
What are the application scenarios for this model?
Primary applications:
• Branched-chain amino acid efflux: ³H-leucine, ³H-valine, ³H-isoleucine efflux assays to characterize LAT4-mediated transport without confounding 4F2hc heterodimer considerations.
• Comparative LAT family studies: parallel analysis with LAT1 and LAT2 (also available from EDITGENE) to dissect transporter-specific functions.
• Cancer metabolism studies: assessment of LAT4 contribution to amino acid handling in cancer contexts.
• Inhibitor specificity: critical genetic control for LAT4-selective compound development.
EDITGENE recommends this model for researchers investigating large neutral amino acid efflux biology and LAT family transporter pharmacology.
Is this SLC43A2 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. LAT4 rescue experiments are well-established for amino acid transport research:
• Construct design: use a codon-modified SLC43A2 sequence with a small C-terminal tag (FLAG, HA). The 12 transmembrane architecture must be preserved.
• 4F2hc independence: unlike LAT1 and LAT2, LAT4 does not require 4F2hc for surface expression — rescue can be performed without co-expression considerations.
• Transport-deficient rescue: substrate-binding pocket mutations enable structure-function studies.
• Functional readout: rescue should restore branched-chain amino acid uptake measured by radiolabel or LC-MS.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download